Hematological Malignancies

US Intergroup Trial E2496 ABVD vs Stanford V in Advanced Stages

Failure – free Survival

1.0 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.0

Probability

5-year FFS

66% vs. 66%

0

1

2

3

4

5

6

7

8

9

10

Year

Treatment Code

fall

Not-Fall

MEDIAN

CONFTOTAL

, ,

80 79

183 180

Stanford V ABVD

263 259